Published in HPB (Oxford) on January 01, 2008
Incidental gallbladder cancer diagnosed following laparoscopic cholecystectomy. World J Surg (2009) 1.25
Incidental pT2-T3 gallbladder cancer after a cholecystectomy: outcome of staging at 3 months prior to a radical resection. HPB (Oxford) (2013) 0.86
Relevance of residual disease after liver resection for incidental gallbladder cancer. HPB (Oxford) (2012) 0.85
Prognostic significance of preoperative platelet count in patients with gallbladder cancer. World J Gastroenterol (2015) 0.78
Evaluation of surgical treatment for incidental gallbladder carcinoma diagnosed during or after laparoscopic cholecystectomy: single center results. BMC Res Notes (2017) 0.78
Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma. World J Gastroenterol (2015) 0.76
Implications of the index cholecystectomy and timing of referral for radical resection of advanced incidental gallbladder cancer. Ann R Coll Surg Engl (2015) 0.75
Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol (2005) 4.92
Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer (1995) 3.01
Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg (2000) 2.43
Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg (1996) 2.39
Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates. Cancer (1992) 2.37
Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg (2006) 1.76
The National Cancer Data Base report on carcinoma of the gallbladder, 1989-1995. Cancer (1998) 1.59
Gallbladder cancer: Defining the indications for primary radical resection and radical re-resection. Ann Surg Oncol (2006) 1.58
Clinical significance of extrahepatic bile duct resection for advanced gallbladder cancer. J Surg Oncol (2006) 1.56
Natural history study of gallbladder cancer: a review of 36 years experience at M. D. Anderson Hospital and Tumor Institute. Cancer (1978) 1.53
Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer. J Am Coll Surg (2001) 1.41
Extensive surgery for carcinoma of the gallbladder. Br J Surg (2002) 1.28
Long-term results after curative resection for carcinoma of the gallbladder. French University Association for Surgical Research. Am J Surg (1998) 1.27
Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol (2004) 1.18
Incidence pattern and survival for gallbladder cancer over three decades--an analysis of 10301 patients. Ann Surg Oncol (2006) 1.17
Early carcinoma of the gallbladder. Eur J Surg (1992) 1.16
Retrospective analysis of 70 operations for gallbladder carcinoma. Br J Surg (1997) 1.11
Post-operative neutrophil-lymphocyte ratio predicts complications following colorectal surgery. Int J Surg (2006) 1.05
Perineural invasion has a negative impact on survival of patients with gallbladder carcinoma. Br J Surg (2002) 1.05
Mode of tumor spread and surgical strategy in gallbladder carcinoma. Langenbecks Arch Surg (2002) 1.03
Primary carcinoma of the gallbladder in Taiwan. J Surg Oncol (1996) 0.99
A curative resection improves the postoperative survival rate even in patients with advanced gallbladder carcinoma. J Gastrointest Surg (2007) 0.98
Factors influencing postoperative hospital mortality and long-term survival after radical resection for stage IV gallbladder carcinoma. World J Surg (2003) 0.98
Trends in incidence and management of gallbladder carcinoma: a population-based study in France. Cancer (2000) 0.97
Significance of extensive surgery including resection of the pancreas head for the treatment of gallbladder cancer--from the perspective of mode of lymph node involvement and surgical outcome. World J Surg (2006) 0.97
Surgical treatment of pT2 gallbladder carcinoma: a reevaluation of the therapeutic effect of hepatectomy and extrahepatic bile duct resection based on the long-term outcome. Ann Surg Oncol (2007) 0.96
Surrogate markers of resectability in patients undergoing exploration of potentially resectable pancreatic adenocarcinoma. J Gastrointest Surg (2007) 0.89
Routine histology of cholecystectomy specimens is unnecessary. Ann R Coll Surg Engl (2007) 0.87
Indications for curative resection of advanced gallbladder cancer with hepatoduodenal ligament invasion. J Hepatobiliary Pancreat Surg (2001) 0.87
Gallbladder cancer: a global perspective. J Surg Oncol (2006) 0.85
Extended hepatic resection for gallbladder cancer. Am J Surg (2007) 0.85
Surgical treatment for Nevin stage IV and V gallbladder carcinoma: report of 70 cases. Hepatobiliary Pancreat Dis Int (2005) 0.84
Aggressive surgical resection for carcinoma of gallbladder. ANZ J Surg (2005) 0.83
Segment III cholangiojejunostomy for carcinoma of the gallbladder. World J Surg (1997) 0.81
The standardized surgical approach improves outcome of gallbladder cancer. World J Surg Oncol (2007) 0.79
Primary carcinoma of the gallbladder: a review of 10 years of experience at Tri-Service General Hospital. Zhonghua Yi Xue Za Zhi (Taipei) (1993) 0.77
The DNA sequence of the human X chromosome. Nature (2005) 6.97
Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes. Lancet (2003) 2.56
Growth stimulation of intestinal commensal Escherichia coli by catecholamines: a possible contributory factor in trauma-induced sepsis. Shock (2002) 2.08
Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature. JOP (2008) 1.97
Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Biomarkers Prev (2005) 1.83
Single-incision laparoscopic cholecystectomy: a systematic review. Arch Surg (2012) 1.82
Total pancreatectomy with and without islet cell transplantation for chronic pancreatitis: a series of 85 consecutive patients. Pancreas (2009) 1.77
Dietary polyphenolic phytochemicals--promising cancer chemopreventive agents in humans? A review of their clinical properties. Int J Cancer (2007) 1.65
Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases. Med Oncol (2015) 1.64
Peer-assisted learning: a novel approach to clinical skills learning for medical students. Med Educ (2007) 1.59
The incidence and success of treatment for severe chronic groin pain after open, transabdominal preperitoneal, and totally extraperitoneal hernia repair. World J Surg (2010) 1.55
Prognostic molecular markers in hepatocellular carcinoma: a systematic review. Eur J Cancer (2007) 1.55
Do anthocyanins and anthocyanidins, cancer chemopreventive pigments in the diet, merit development as potential drugs? Cancer Chemother Pharmacol (2009) 1.51
Pilot study of oral anthocyanins for colorectal cancer chemoprevention. Cancer Prev Res (Phila) (2009) 1.50
Is intraoperative confirmation of malignancy during pancreaticoduodenectomy mandatory? J Gastrointest Surg (2011) 1.50
Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol (2007) 1.49
Pilot study of oral silibinin, a putative chemopreventive agent, in colorectal cancer patients: silibinin levels in plasma, colorectum, and liver and their pharmacodynamic consequences. Clin Cancer Res (2006) 1.39
Liver metastases from colorectal cancer: radioembolization with systemic therapy. Nat Rev Clin Oncol (2009) 1.24
Islet auto transplantation following total pancreatectomy: a long-term assessment of graft function. Pancreas (2008) 1.24
Efficacy and safety of microwave ablation for primary and secondary liver malignancies: a systematic review. Eur J Gastroenterol Hepatol (2009) 1.21
Prognostic molecular markers in cholangiocarcinoma: a systematic review. Eur J Cancer (2008) 1.21
Systematic review of minimally invasive pancreatic resection. J Gastrointest Surg (2009) 1.21
Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals. Acta Pharmacol Sin (2007) 1.15
Abdominal adhesion prevention: still a sticky subject? Dig Surg (2010) 1.09
Pancreatectomy with islet autotransplantation for the treatment of severe chronic pancreatitis: the first 40 patients at the leicester general hospital. Transplantation (2003) 1.08
Hepatic microwave ablation: a review of the histological changes following thermal damage. Liver Int (2008) 1.06
Notch3 and HEY-1 as prognostic biomarkers in pancreatic adenocarcinoma. PLoS One (2012) 1.05
Incidence and survival for hepatic, pancreatic and biliary cancers in England between 1998 and 2007. Cancer Epidemiol (2012) 1.03
Expression of nuclear Notch3 in pancreatic adenocarcinomas is associated with adverse clinical features, and correlates with the expression of STAT3 and phosphorylated Akt. J Surg Oncol (2008) 1.01
Use of a modified chitosan-dextran gel to prevent peritoneal adhesions in a rat model. J Surg Res (2010) 1.00
Preoperative early warning scores can predict in-hospital mortality and critical care admission following emergency surgery. J Surg Res (2008) 0.97
Total pancreatectomy with islet autotransplantation: an overview. HPB (Oxford) (2009) 0.97
Prolonged biologically active colonic tissue levels of curcumin achieved after oral administration--a clinical pilot study including assessment of patient acceptability. Cancer Prev Res (Phila) (2012) 0.96
Hypoxia and angiogenesis in pancreatic cancer. ANZ J Surg (2006) 0.95
Isolated Roux-loop pancreaticojejunostomy: a series of 61 patients with zero postoperative pancreaticoenteric leaks. J Gastrointest Surg (2004) 0.95
Staging laparoscopy for hilar cholangiocarcinoma in 100 patients. Langenbecks Arch Surg (2013) 0.94
Predictors of severity and survival in acute pancreatitis: validation of the efficacy of early warning scores. Pancreas (2008) 0.93
Percutaneous splanchnic nerve radiofrequency ablation for chronic abdominal pain. ANZ J Surg (2005) 0.93
Radiofrequency ablation versus resection for liver tumours: an evidence-based approach to retrospective comparative studies. J Gastrointest Surg (2011) 0.93
Changes in interleukin-1β and 6 after hepatic microwave tissue ablation compared with radiofrequency, cryotherapy and surgical resections. Am J Surg (2010) 0.92
Subtotal hepatectomy: a porcine model for the study of liver regeneration. J Surg Res (2004) 0.91
Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis. Eur J Cancer Prev (2009) 0.91
Bilirubin levels predict malignancy in patients with obstructive jaundice. HPB (Oxford) (2011) 0.91
Blood Transfusion Policies in Elective General Surgery: How to Optimise Cross-Match-to-Transfusion Ratios. Transfus Med Hemother (2013) 0.91
Preoperative systemic inflammation and infectious complications after resection of colorectal liver metastases. Arch Surg (2011) 0.91
Pooled survival and response data from phase III randomized controlled trials for gemcitabine-based regimes in the treatment of advanced pancreatic cancer. Am J Clin Oncol (2013) 0.90
The diagnosis and management of Sphincter of Oddi dysfunction: a systematic review. Langenbecks Arch Surg (2012) 0.90
Overexpression of the Nek2 kinase in colorectal cancer correlates with beta-catenin relocalization and shortened cancer-specific survival. J Surg Oncol (2014) 0.90
Liver electrolysis: pH can reliably monitor the extent of hepatic ablation in pigs. Clin Sci (Lond) (2002) 0.90
Immunoregulatory effects of liver ablation therapies for the treatment of primary and metastatic liver malignancies. Liver Int (2008) 0.90
Surgical bypass vs. endoscopic stenting for pancreatic ductal adenocarcinoma. HPB (Oxford) (2009) 0.90
The porcine hepatic arterial supply, its variations and their influence on the extracorporeal perfusion of the liver. J Surg Res (2009) 0.89
Curcumin ameliorates oxaliplatin-induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo. Int J Cancer (2010) 0.89
Actinomycosis of the sigmoid colon: an unusual cause of large bowel perforation. ANZ J Surg (2004) 0.89